ARTICLE | Company News
HitGen to discover small molecules for Aduro
September 1, 2017 3:07 PM UTC
HitGen Ltd. (Chengdu, China) said it partnered with immuno-oncology company Aduro Biotech Inc. (NASDAQ:ADRO) in a multi-year deal to discover small molecules against multiple undisclosed targets of i...